Eli Lilly (LLY) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Eli Lilly And Company  (NYSE: LLY)
 

Eli Lilly Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Eli Lilly And's inventory turnover ratio sequentially decreased to 0.89 in the third quarter 2026, unsurprisingly, as the Eli Lilly And markets continue to deteriorate, and LLY's faces growing challenges to bring down its inventories. Eli Lilly And's average inventory processing period in the Sep 30 2026 quarter, has increased to 410 days, from 397 days, in the Jun 30 2026 quarter.

Within Healthcare sector 324 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1852, from total ranking in the second quarter 2026 at 2090.

LLY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eli Lilly And Company Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LLY Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 49.37 % 52.47 % 56.04 % 81.1 % 63.28 %
Y / Y Cost of Sales Growth 30.74 % 33.51 % 60.82 % 40.27 % 38.58 %
Inventory Turnover Ratio (TTM) 0.89 0.92 0.96 0.96 1.01
LLY's Total Ranking # 1852 # 2090 # 1905 # 1891 # 1886
Average inventory processing period 408 395 379 382 363
Seq. Inventory Growth 8.34 % 15.58 % 5.71 % 12.84 % 10.59 %
Seq. Cost of Sales Growth 20.35 % -8.64 % 6.09 % 12.08 % 22.9 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 98
Healthcare Sector # 325
Overall Market # 1852

Inventory Turnover Ratio Statistics
High Average Low
2.09 1.56 0.89
(June 30. 2012)   (Sep 30 2026)



LLY Company Profile >> Back to LLY Efficiency Comparisons >> Compare LLY Inventory Turnover Ratio to its Competitors

Financial Statements
Eli Lilly And's Inventories $ 18,194 Millions Visit LLY's Balance sheet
Eli Lilly And's Cost of Revenues TTM $ 14,150 Millions Visit LLY's Income Statement
What are LLY's Sales? Visit LLY's Sales by Segment

Other Inventory Turnover Ratios
Eli Lilly And's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LLY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LLY's Competitors
Inventory Turnover Ratio for LLY's Suppliers
Inventory Turnover Ratio for LLY's Customers

You may also want to know
LLY's Sales Growth Rates LLY's Pe Price to earnings ratio LLY's Receivables Turnover Ratio LLY's Stock Quote
LLY's Net Income Growth Rates LLY's Ps Price to Sales ratio LLY's Sales per Employee LLY's Asset Turnover Ratio
LLY's Net Margin LLY's Pb Price to Book ratio LLY's Financial Strength Ratios LLY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Halozyme Therapeutics Inc   2.13 $ 319.654  Millions$ 150  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Boston Scientific Corporation  2.06 $ 6,502.000  Millions$ 3,153  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.03 $ 16.819  Millions$ 8  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Alpha Pro Tech Ltd   1.97 $ 40.363  Millions$ 21  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Trisalus Life Sciences Inc   1.86 $ 7.291  Millions$ 4  Millions
Elutia Inc   1.84 $ 3.772  Millions$ 2  Millions
Amgen Inc   1.81 $ 11,319.000  Millions$ 6,255  Millions
Haemonetics Corporation  1.80 $ 558.423  Millions$ 310  Millions
Orthofix Medical Inc   1.78 $ 244.423  Millions$ 137  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Harvard Bioscience Inc   1.76 $ 38.986  Millions$ 22  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Ocular Therapeutix Inc   1.66 $ 6.389  Millions$ 4  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions
Bio rad Laboratories Inc   1.64 $ 1,264.000  Millions$ 769  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Sanuwave Health Inc   1.54 $ 9.845  Millions$ 6  Millions

Date modified: 2026-10-30T13:15:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.